VitaNova Life Sciences (VNOV) EPS (Weighted Average and Diluted) (2017 - 2026)
VitaNova Life Sciences (VNOV) reported EPS (Weighted Average and Diluted) of -$0.01 for Q1 2026, down 200.0% on a YoY basis from $0.01 in Q1 2025, and down 798.47% quarter-over-quarter from $0.0 in Q4 2025.
VitaNova Life Sciences (VNOV) EPS (Weighted Average and Diluted) (2017 - 2026) Analysis & Trends
VitaNova Life Sciences has reported EPS (Weighted Average and Diluted) for 8 years, with the latest figure at -$0.01 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 200.0% year-over-year to -$0.01; the trailing twelve-month figure through Jan 2026 stood at $0.01 (down 50.0% YoY), and the FY2025 full-year result was $0.03, up 200.0% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.01, down from $0.0 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $0.02 in Q2 2025, with the low at -$0.01 in Q1 2026.
- Historically, EPS (Weighted Average and Diluted) has averaged $0.0 across 5 years, with a median of $0.0 in 2024.
- Annual changes were most pronounced in 2023 — EPS (Weighted Average and Diluted) slumped 1236.22% — and 2025, when it soared 4105.16%.
- VitaNova Life Sciences' EPS (Weighted Average and Diluted) stood at $0.0 in 2022, then sank by 436.6% to -$0.0 in 2023, then surged by 187.53% to $0.0 in 2024, then gained by 9.69% to $0.0 in 2025, then sank by 798.47% to -$0.01 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.01 (Q1 2026), $0.0 (Q4 2025), and -$0.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 13.65 |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 8.40 |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 1.69 |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 0.92 |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -0.08 |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -0.24 |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -0.20 |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -0.06 |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | -0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -0.01 |
| Oct 31, 2025 | 0.00 |
| Jul 31, 2025 | 0.00 |
| Apr 30, 2025 | 0.02 |
| Jan 31, 2025 | 0.01 |
| Oct 31, 2024 | 0.00 |
| Jul 31, 2024 | 0.00 |
| Apr 30, 2024 | 0.01 |
| Jan 31, 2024 | 0.00 |
| Oct 31, 2023 | 0.00 |
| Jul 31, 2023 | 0.00 |
| Apr 30, 2023 | 0.00 |
| Jan 31, 2023 | 0.00 |
| Oct 31, 2022 | 0.00 |
| Jul 31, 2022 | 0.00 |
| Apr 30, 2022 | 0.00 |
| Jan 31, 2022 | 0.00 |
| Oct 31, 2021 | 0.00 |
| Jul 31, 2021 | 0.02 |
| Apr 30, 2021 | 0.00 |